State of the art on nailfold capillaroscopy: A reliable diagnostic tool and putative biomarker in rheumatology?

Rheumatology (United Kingdom)

Volumn 52, Issue 11, 2013, Pages 1933-1940

  Cutolo, Maurizio ^a   Smith, Vanessa ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Capillaroscopy; Classification criteria; Clinical complications; Connective tissue diseases; Differential diagnosis; EULAR; Microcirculation; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; BIOLOGICAL MARKER;

CAPILLAROSCOPY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FINGER ULCER; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; LASER; LUNG; LUNG DISEASE; MICROANGIOPATHY; MICROCIRCULATION; MICROSCOPE; MICROVASCULATURE; NAILFOLD CAPILLAROSCOPY; PILOT STUDY; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOLOGY; SCLERODERMA;

CAPILLAROSCOPY; CLASSIFICATION CRITERIA; CLINICAL COMPLICATIONS; CONNECTIVE TISSUE DISEASES; DIFFERENTIAL DIAGNOSIS; EULAR; MICROCIRCULATION; RAYNAUD'S PHENOMENON; SYSTEMIC SCLEROSIS;

BIOLOGICAL MARKERS; CONNECTIVE TISSUE DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; MICROCIRCULATION; MICROSCOPIC ANGIOSCOPY; NAILS; PROGNOSIS; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC;

EID: 84886261339     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket153     Document Type: Review

References (59)

1. Cutolo M. Capillaroscopy in rheumatic diseases. From the XVIII to the XXI century. In: Cutolo M, ed. Atlas of Capillaroscopy in Rheumatic Diseases. Vol. 1. Milano: Elsevier Srl, 2010:3-5.
2. Spencer-Green G. Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 1998;158:595-600.
3. Guillevin L. A contemporary update on scleroderma. Clin Rev Allergy Immunol 2011;40:75-7.
4. Herrick AL. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat Rev Rheumatol 2012;8: 469-79.
5. Herrick AL, Cutolo M. Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum 2010;62: 2595-604.
6. Cutolo M, Grassi W, Matucci Cerinic M. Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 2003;48:3023-30.
7. Andrade LE, Gabriel Junior A, Assad RL et al. Panoramic nailfold capillaroscopy: a new reading method and normal range. Semin Arthritis Rheum 1990;20:21-31.
8. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
9. Smith V. When and how to perform the capillaroscopy. In: Cutolo M, ed. Atlas of Capillaroscopy in Rheumatic Diseases. Vol. 1. Milano: Elsevier Srl, 2010:33-42.
10. Cutolo M, Sulli A, Pizzorni C et al. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155-60.
11. Cutolo M, Sulli A, Smith V. Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 2010;6:578-87.
12. Smith V, Pizzorni C, De Keyser F et al. Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a twocentre study. Ann Rheum Dis 2010;69:1092-6.
13. Koenig M, Joyal F, Fritzler MJ et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008;58:3902-12.
14. Cutolo M, Pizzorni C, Sulli A. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al. Arthritis Rheum 2007;56:2102-3.
15. Maricq HR, Leroy EC. Patterns of finger capillary abnormalities in connective-tissue disease by wide-field microscopy. Arthritis Rheum 1973;16:619-28.
16. Maricq HR, Leroy EC, D'angelo WA et al. Diagnostic potential of in vivo microscopy in scleroderma and related disorders. Arthritis Rheum 1980;23:183-9.
17. Lonzetti LS, Joyal F, Raynauld JP et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001;44:735-6.
18. Avouac J, Fransen J, Walker UA et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 2011;70: 476-81.
19. Fransen J, Johnson SR, van den Hoogen F et al. Items for developing revised classification criteria in systemic sclerosis: results of a consensus exercise. Arthritis Care Res 2012;64:351-7.
20. Maricq HR. Widefield capillary microscopy. Technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 1981; 24:1159-65.
21. Maricq HR, Harper FE, Khan MM et al. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective-tissue disease. Clin Exp Rheumatol 1983;1:195-205.
22. Sulli A, Secchi ME, Pizzorni C et al. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008;67: 885-7.
23. Maricq HR. Comparison of quantitative and semiquantitative estimates of nailfold capillary abnormalities in scleroderma spectrum disorders. Microvasc Res 1986;32: 271-6.
24. Cutolo M, Sulli A, Secchi ME et al. The contribution of capillaroscopy to the differential diagnosis of connective autoimmune diseases. Best Pract Res Clin Rheumatol 2007;21:1093-108.
25. Hofstee HM, Serne EH, Roberts C et al. A multicentre study on the reliability of qualitative and quantitative nailfold videocapillaroscopy assessment. Rheumatology 2012;51:749-55.
26. Ingegnoli F, Gualtierotti R, Lubatti C et al. Feasibility of different capillaroscopic measures for identifying nailfold microvascular alterations. Semin Arthritis Rheum 2009;38: 289-95.
27. Moore TL, Roberts C, Murray AK et al. Reliability of dermoscopy in the assessment of patients with Raynaud's phenomenon. Rheumatology 2010;49:542-7.
28. Bukhari M, Hollis S, Moore T et al. Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy. Rheumatology 2000;39:506-12.
29. Anderson ME, Allen PD, Moore T et al. Computerized nailfold video capillaroscopy-a new tool for assessment of Raynaud's phenomenon. J Rheumatol 2005;32:841-8.
30. Hettema ME, Zhang D, Stienstra Y et al. No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis. Clin Rheumatol 2009;28: 825-33.
31. Cutolo M, Zampogna G, Vremis L et al. Longterm effects of Endothelin receptor antagonism on microvascular damage evaluated by nailfold capillaroscopic analysis in systemic sclerosis. J Rheumatol 2013;40:40-5.
32. Miniati I, Guiducci S, Conforti ML et al. Autologous stem cell transplantation improves microcirculation in systemic sclerosis. Ann Rheum Dis 2009;68:94-8.
33. Shah P, Murray AK, Moore TL et al. Effects of iloprost on microvascular structure assessed by nailfold videocapillaroscopy: a pilot study. J Rheumatol 2011;38:2079-80.
34. Bredemeier M, Xavier RM, Capobianco KG et al. Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 2004; 31:286-94.
35. Caramaschi P, Canestrini S, Martinelli N et al. Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology 2007;46:1566-9.
36. Hofstee HMA, Noordegraaf AV, Voskuyl AE et al. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis 2009;68:191-5.
37. Sulli A, Pizzorni C, Smith V et al. Timing of transition between capillaroscopic patterns in systemic sclerosis. Arthritis Rheum 2012;64:821-5.
38. Sebastiani M, Manfredi A, Colaci M et al. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum 2009;61:688-94.
39. Smith V, De Keyser F, Pizzorni C et al. Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. Ann Rheum Dis 2011;70:180-3.
40. Sebastiani M, Manfredi A, Vukatana G et al. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann Rheum Dis 2012;71:67-70.
41. Smith V, Decuman S, Sulli A et al. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study. Ann Rheum Dis 2012; 71:1636-9.
42. Liakouli V, Cipriani P, Marrelli A et al. Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev 2011;10:590-4.
43. Distler JH, Gay S, Distler O. Angiogenesis and vasculogenesis in systemic sclerosis. Rheumatology 2006;45: S26-7.
44. Avouac J, Vallucci M, Smith V et al. Low circulating endothelial progenitor cell levels and high VEGF serum levels are associated with the late nailfold capillarosopic pattern in systemic sclerosis. Arthritis Rheum 2012;64: S647-8.
45. Riccieri V, Stefanantoni K, Vasile M et al. Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis. Clin Exp Rheumatol 2011;29:S46-52.
46. Distler O, Del Rosso A, Giacomelli R et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 2002;4:R11.
47. Kim HS, Park MK, Kim HY et al. Capillary dimension measured by computer-based digitalized image correlated with plasma endothelin-1 levels in patients with systemic sclerosis. Clin Rheumatol 2010;29:247-54.
48. Sulli A, Soldano S, Pizzorni C et al. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis. J Rheumatol 2009; 36:1235-9.
49. Riccieri V, Germano V, Alessandri C et al. More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis? Clin Exp Rheumatol 2008;26:992-7.
50. Cutolo M, Pizzorni C, Tuccio M et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 2004;43:719-26.
51. Imbert B, Carpentier PH. Techniques for evaluating the microcirculation. In: Cutolo M, ed. Atlas of Capillaroscopy in Rheumatic Diseases. Vol. 1. Milano: Elsevier Srl, 2010:17-23.
52. Murray AK, Moore TL, Manning JB et al. Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders. Arthritis Rheum 2009;61:1103-11.
53. Rosato E, Molinaro I, Rossi C et al. The combination of laser Doppler perfusion imaging and photoplethysmography is useful in the characterization of scleroderma and primary Raynaud's phenomenon. Scand J Rheumatol 2011;40:292-8.
54. Cutolo M, Ferrone C, Pizzorni C et al. Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study. J Rheumatol 2010;37:1174-80.
55. Roustit M, Millet C, Blaise S et al. Excellent reproducibility of laser speckle contrast imaging to assess skin microvascular reactivity. Microvasc Res 2010;80:505-11.
56. Ruaro B, Sulli A, Bernero E et al. Comparison between two different laser techniques to evaluate peripheral blood perfusion in systemic sclerosis patients. Reumatismo 2012;64:335-9.
57. De Angelis R, Grassi W, Cutolo M. A growing need for capillaroscopy in rheumatology. Arthritis Rheum 2009;61: 405-10.
58. Bandinelli F, Bijlsma JW, Ramiro MS et al. Rheumatology education in Europe: results of a survey of young rheumatologists. Clin Exp Rheumatol 2011;29:843-5.
59. Cutolo M, Smith V, Sulli A. Training in capillaroscopy: a growing interest. J Rheumatol 2012;39:1113-6.